Market Newsdesk

Company advancing development of its modified version of Interleukin-18 (IL-18

^{Binding Protein Resistant}

or IL-18

^BPR

) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory IL-18 Binding Protein (IL-18BP)
thus making IL-18

^BPR

more effective in vitro

Sonnet’s variant human IL-18

^BPR

is a key cytokine which comprises substitutions at the following amino acid positions: Y1, M51, M60, S105 and D110, relative to human wildtype IL-18

Patent opens up potential licensing opportunities for rights to IL-18

^BPR

independent of Sonnet’s F

_H

AB platform patent estate

Management releases “What This Means” segment discussing the allowed patent;

Access here

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance to the Company for a second patent in the IL-18 variant protein field which discloses the amino acid sequence of its variant human IL-18^BPR protein. The allowed patent claims cover variant human IL-18 (hIL-18) proteins, including but not limited to hIL-18 proteins having amino acid substitutions at the following positions: Y1W, Y1K, M51Y, M51S, M60W, S105E, and D110Y, relative to human wildtype IL-18. Additionally, the Company announced the release of a Virtual Investor “What This Means” segment to discuss the allowed patent, which is now available here.

“I believe that Sonnet has become of one of the few companies that hold proprietary rights to IL-18^BPR which could be a highly valuable cytokine for cancer patients. This patent covers the composition of matter of the amino acid sequence of our human IL-18^BPR variant protein which bolsters our intellectual property position and provides further validation to our approach that when IL-18^BPR is synergistically combined with IL-12, we believe we will have the potential to develop an important therapeutic asset for oncology and cell-based therapy. Additionally, we feel that this patent enables us to explore opportunities for IL-18^BPR to be licensed independent of our F_HAB platform. We continue to believe that novel bifunctional molecules such as SON-1411, when combined with our proprietary F_HAB platform, have the potential to demonstrate improved tumor targeting, extended half-life and an enhanced therapeutic window,” said Pankaj Mohan, Ph.D., Sonnet Founder and Chief Executive Officer.

Sonnet previously reported the generation of two novel drug candidates, SON-1411 (IL18^BPR-F_HAB-IL12) and SON-1400 (IL18^BPR-F_HAB), each containing a variant version of recombinant human interleukin-18 (IL-18^BPR). SON-1411 is a proprietary bifunctional fusion protein consisting of IL-18^BPR combined with single-chain wild-type IL-12, linked to Sonnet’s Fully Human Albumin Binding (F_HAB^®) platform while SON-1400 is a monofunctional fusion protein comprising the same IL-18^BPR domain linked to the F_HAB. F_HAB extends the half-life and biological activity of linked molecules by binding native albumin in the serum and targets the tumor microenvironment (TME) through high affinity binding to glycoprotein 60 (gp60) and the Secreted Protein Acidic and Rich in Cysteine (SPARC).

“SON-1411 (IL18^BPR-F_HAB-IL12) is a bifunctional combination of IL-12 and the F_HAB domain with a human variant of human interleukin-18 (“IL-18^BPR”), which was modified to resist an inhibitory interaction with IL-18 binding protein (IL-18BP). IL-18 is involved in activating both innate and adaptive immune responses; however, IL-18 clinical therapies have been hampered by a lack of efficacy due to the inhibitory activity of the IL-18BP,” commented John Cini, Ph.D., Sonnet Chief Scientific Officer.

About SON-1411

SON-1411 is a candidate immunotherapeutic recombinant drug that is closely related to and will replace SON-1410, which links an unmodified single-chain human IL18 and an unmodified IL-12 with the albumin-binding domain of the single-chain antibody fragment A10m3. The only difference between SON-1410 and SON-1411 is that in the latter, the IL-18 domain has been modified via mutagenesis to retain wildtype binding to the IL-18 receptor (IL-18 Rc) while inhibiting or abolishing binding to the IL-18 binding protein (IL-18 BP). The A10m3 scFv was selected to bind both at normal pH, as well as at the acidic pH that is typically found in the TME. The F_HAB technology targets tumor and lymphatic tissue, providing a mechanism for dose sparing and an opportunity to improve the safety and efficacy profile of IL-18 and IL-12, as well as a variety of potent immunomodulators that can be added using the platform. Interleukin-12 can orchestrate a robust immune response to many cancers and pathogens. Given the types of proteins induced in the TME, such as SPARC and gp60, several types of cancer such as non-small cell lung cancer, melanoma, head and neck cancer, sarcoma, and some gynecological cancers are particularly relevant for this approach. SON-1411 is designed to deliver IL-18^BPR and IL-12 to local tumor tissue, turning ‘cold’ tumors ‘hot’ by stimulating IFNγ, which activates innate and adaptive immune cell responses and increases the production of Programed Death Ligand 1 (PD-L1) on tumor cells.

About Sonnet BioTherapeutics Holdings, Inc.

Sonnet is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action. Known as F_HAB (Fully Human Albumin-Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Sonnet’s F_HAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. F_HAB platform is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.

Sonnet’s lead program, SON-1010, or IL-12-F_HAB, is in development for the treatment of advanced solid tumors, certain types of sarcoma, and platinum-resistant ovarian cancer (PROC). SON-1010 is being evaluated in an ongoing Phase 1/2a study through a Master Clinical Trial and Supply Agreement with Roche in combination with atezolizumab (Tecentriq^®) for the treatment of PROC. The Company is also evaluating its second product candidate, SON-1210, an IL12-F_HAB-IL15 bifunctional for solid tumors, in collaboration with the Innovative Immuno-Oncology Consortium (IIOC), and plans to commence an investigator-initiated and funded Phase 1/2a study for the treatment of locally-advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).

The Company’s SON-080 program is a low dose of rhIL-6 in development for Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN). SON-080 demonstrated encouraging results in a Phase 1b/2a clinical trial, being well tolerated with no evidence of a pro-inflammatory cytokine response. In October 2024, Sonnet announced a license agreement with Alkem Laboratories, Inc. who will assume responsibility for advancing development of the SON-080 program into a Phase 2 study in DPN in India.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the impact of the second patent in the IL-18 variant protein field, outcome of the Company’s clinical trials, the Company’s cash runway, the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential, “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor
Relations
Contact:

JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected] 

COOTAMUNDRA, Australia, March 19, 2025 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced that it is seeing surging demand for its canola oil products from China in response to the ongoing trade war between China and Canada.

“Our high-quality oils are well positioned for growth in China and the partnership with Shanghai Maiwei Trading Co., which we announced in January 2025, provides a strong foundation to capitalize on the recent surge in demand for our canola oil,” said Gary Seaton, Chief Executive Officer. “We have received numerous inquiries from both private and state-owned enterprises and anticipate entering into several long-term supply agreements with Chinese companies over the next 12 months.”

According to the United States Trade Representative (USTR), in 2024, the United States (US) goods trade with Australia totaled an estimated $51.3 billion, with US goods exports to Australia at $34.6 billion and imports from Australia at $16.7 billion, resulting in a trade surplus of $17.9 billion for the US.  Currently, a majority of sales are from the domestic market through major supermarkets and retailers, thus any current or future trade tariff’s implemented by US are expected to have no significant impact on sales or profitability of business.

About Australian Oilseeds Investments Pty Ltd. Australian Oilseeds Investments Pty Ltd. is an Australian proprietary company that, directly and indirectly through its subsidiaries, is focused on the manufacture and sale of sustainable oilseeds (e.g., seeds grown primarily for the production of edible oils) and is committed to working with all suppliers in the food supply chain to eliminate chemicals from the production and manufacturing systems to supply quality products to customers globally. The Company engages in the business of processing, manufacture and sale of non-GMO oilseeds and organic and non-organic food-grade oils, for the rapidly growing oilseeds market, through sourcing materials from suppliers focused on reducing the use of chemicals in consumables in order to supply healthier food ingredients, vegetable oils, proteins and other products to customers globally. Over the past 20 years, the Company’s cold pressing oil plant has grown to become the largest in Australia, pressing strictly GMO-free conventional and organic oilseeds.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our financial outlook, business strategy and plans, market trends and market size, opportunities and positioning. These forward-looking statements are based on current expectations, estimates, forecasts and projections. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall” and variations of these terms and similar expressions are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. For example, global economic conditions could in the future reduce demand for our products; we could in the future experience cybersecurity incidents; we may be unable to manage or sustain the level of growth that our business has experienced in prior periods; our financial resources may not be sufficient to maintain or improve our competitive position; we may be unable to attract new customers, or retain or sell additional products to existing customers; we may experience challenges successfully expanding our marketing and sales capabilities, including further specializing our sales force; customer growth could decelerate in the future; we may not achieve expected synergies and efficiencies of operations from recent acquisitions or business combinations, and we may not be able to pay off our convertible notes when due. Further information on potential factors that could affect our financial results is included in our most recent Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission. The forward-looking statements included in this press release represent our views only as of the date of this press release and we assume no obligation and do not intend to update these forward-looking statements.

Contact

Australian Oilseeds Holdings Limited
126-142 Cowcumbla Street
Cootamundra New South Wales 2590
Attn: Bob Wu, CFO
Email: [email protected]

Investor Relations Contact

Reed Anderson
(646) 277-1260
[email protected]

PALM BEACH, Fla., March 19, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – Industry insiders are saying that the mortgage industry is undergoing a transformative shift with the integration of Artificial Intelligence (AI). This cutting-edge technology is revolutionizing various aspects of the mortgage process, from application to regulatory compliance. A recent article by one such insider focused on AI in the Mortgage Industry said: “In the contemporary landscape of the mortgage industry, the infusion of Artificial Intelligence (AI) has ushered in a paradigm shift, influencing various facets of the lending process. Embracing AI in mortgage services has become synonymous with innovation, offering a spectrum of benefits to both lenders and borrowers. AI in mortgage industry manifests through sophisticated algorithms and machine learning models that power automated decision-making processes, commonly known as AI mortgage services. These services streamline and optimize tasks such as underwriting and risk assessment, ensuring faster and more accurate lending decisions. The integration of AI in mortgage lending not only expedites processes but also enhances the overall efficiency of loan origination.” Active Companies in the markets today include: Beeline Holdings, Inc. (NASDAQ: BLNE), Rocket Companies (NYSE: RKT), Redfin Corporation (NASDAQ: RDFN), loanDepot, Inc. (NYSE: LDI), Better Home & Finance Holding Company (NASDAQ: BETR).

The article continued: “One of the key advantages of AI in the mortgage industry lies in its ability to provide personalized experiences for borrowers. AI-driven virtual assistants navigate complex mortgage terms, address borrower queries, and facilitate smoother communication channels. This not only fosters customer satisfaction but also contributes to a more transparent and engaging lending experience. The role of AI in the mortgage industry goes beyond individual transactions; it extends to the broader scope of the industry itself. Artificial intelligence in mortgage lending is a proactive force in fraud detection and prevention. Through the analysis of intricate patterns in financial data, AI can identify anomalies and potential fraudulent activities, bolstering the security of mortgage transactions and safeguarding the interests of both lenders and borrowers.”

Beeline Holdings, Inc. (NASDAQ: BLNE) AI Sales Agent ‘Bob 2.0’ Delivers 6X More Leads than Human Chat – Revolutionizing Mortgage Sales at Near Zero Cost – Beeline Holdings, Inc. (#BLNE), a leader in AI-driven mortgage technology, has launched Bob 2.0, the next evolution of its AI-powered sales agent, driving a 6X increase in qualified leads over human agents while running 24/7 at minimal cost.

“Bob changes the game for scaling front-end mortgage operations,” said Nick Liuzza, CEO of Beeline. “With Bob we’re able to engage more prospects, generate more leads, and streamline sales, all while keeping our Loan Guides focused on closing deals.” Bob is among the 1st ever AI Mortgage sales bots and was released by Beeline in June 2023.

AI That Delivers Real Results:

Bob 2.0 doesn’t just respond to inquiries—it actively drives conversations toward a sales outcome:

• Engages 3X more website visitors than standard chat solutions
• Delivers 6X more leads from conversations—double the industry standard
• Generates 8X more mortgage applications
• Operates 24/7, handling lead generation tasks at a scale no human team could match

Bob’s Adaptive AI—A Smarter Sales Agent

What sets Bob apart is its ability to respond, adapt, and sell like a human—but without fatigue, missed opportunities, or salary and other overhead. Bob can:

• Guide users through personalized sales journeys based on proven strategies
• Maintain focus in conversations, handling interruptions with precision
• Retain and apply user-provided details, ensuring seamless interactions
• Recognize buyer motivations, responding in a way that builds trust and engagement
• Support Spanish-language interactions, automatically adapting based on user preferences

Beyond Chat: Bob Is Expanding Into SMS, Voice & Live Appointments

Bob’s evolution is far from over. Over the next 90 days, Beeline will integrate Bob with:

• Calendly-powered appointment booking and live handovers to Loan Guides
• AI-driven SMS and voice channels to qualify leads and assist customers throughout the loan application process
• Real-time loan approvals—turning mortgage origination into a 24/7 operation

Future Expansion: AI-Powered Underwriting & Market Growth

Bob’s success has spurred the launch of MagicBlocks, an AI startup seed-funded by Beeline, to bring its AI-powered sales technology to a broader market. Looking ahead, Bob is expected to begin underwriting by Q3 2025, adding a new level of efficiency and further streamlining Beeline’s mortgage process. “As the mortgage market normalizes, AI gives us the ability to scale operations dynamically without added costs,” said Liuzza. “Bob is just the beginning of how AI will redefine mortgage lending.” Continued…Read more about BLNE by going to: https://makeabeeline.com/investor-relations/

Other recent developments in the markets include:

Rocket Companies (NYSE: RKT), the Detroit-based fintech platform consisting of mortgage, real estate and personal finance businesses, recently announced it has entered into an agreement to purchase Redfin Corporation (NASDAQ: RDFN), a leading digital real estate brokerage, in an all-stock transaction for a value of $12.50 per Redfin share, or $1.75 billion of equity value.

“Rocket and Redfin have a unified vision of a better way to buy and sell homes,” said Varun Krishna, CEO of Rocket Companies. “Together, we will improve the experience by connecting traditionally disparate steps of the search and financing process with leading technology that removes friction, reduces costs and increases value to American homebuyers.”

For 40 years, Rocket’s digital platform has grown to provide home financing in all 50 states across 3,000+ counties and parishes. By combining Redfin’s home search and real estate agent network with Rocket’s mortgage origination and servicing capabilities, the company envisions a more seamless experience from search to close, to servicing and future transactions.

“Rocket and Redfin’s approaches to lending and brokerage service have always been two halves of one vision to make the whole home-buying process magical,” said Glenn Kelman, CEO of Redfin. “We want a customer to be able to check her phone to find out what she can afford, see which homes are just right for her, schedule a tour with a local, expert Redfin agent, and get pre-qualified for a loan, all in a matter of minutes. Varun and I see how much better real estate could be when AI guides customers not just through that first step in their search, but all the way home, through the sale, the loan and then a lifetime of accumulating equity and wealth.”

loanDepot, Inc. (NYSE: LDI), (together with its subsidiaries, “loanDepot” or the “Company”), a leading provider of products and services that power the homeownership journey, recently announced results for the fourth quarter ended December 31, 2024.

“2024 was a year of significant progress for loanDepot with the completion of our Vision 2025 strategic program,” said President and Chief Executive Officer Frank Martell. “The strategic imperatives of Vision 2025 served as our roadmap for successfully navigating the historical downturn in the housing and mortgage markets over the past three years. As the Company enters 2025, I believe team loanDepot is positioned to accelerate revenue growth and continue our progress towards sustainable profitability under the auspices of Project North Star that we announced in November 2024, and under Anthony Hsieh’s new leadership that was announced last week.

Better Home & Finance Holding Company (NASDAQ: BETR), the leading digital homeownership company, recently announced record growth in its Home Equity Line of Credit (HELOC) and Home Equity Loan (HELOAN) business, scaling loan volume 400% from $15 million per month in January 2024 to $60 million per month by October 2024. This acceleration establishes Better as the fastest-growing digital home equity lender in the market.

As traditional mortgage demand fluctuates, Better’s suite of home equity products helps strategically diversify its lending volume segments and helps homeowners access fast and flexible home equity lending solutions across market cycles. Better’s implementation of Betsy™ — the Company’s voice-based AI loan assistant — into its product funnel has since facilitated its home equity lending growth, cutting response times from hours to seconds while operating 24/7, 365 days a year with greater speed and cost efficiency than traditional lenders or mortgage call centers. The Company’s lending volume is also fueled by strategic partnerships with mortgage brokers and lenders who leverage Better’s technology and capital to offer HELOCs and HELOANs under correspondent and white-label arrangements.

About FN Media Group:

At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #tickertagpressreleases #pressreleases

Follow us on Facebook to receive the latest news updates:
https://www.facebook.com/financialnewsmedia



Follow us on Twitter for real time Market News:
https://twitter.com/FNMgroup



Follow us on Linkedin:
https://www.linkedin.com/in/financialnewsmedia/

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated twenty five hundred dollars for news coverage of the current press releases issued by Beeline Holdings, Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:
Media Contact email: [email protected] – +1(561)325-8757

SOURCE: FN Media Group

• CMMC Level 2 Compliance Reflects Xometry’s Adherence To Cybersecurity And Information Security Standards For The Aerospace And Defense Industries
• CMMC Compliance Ensures Companies Doing Business With U.S. Department of Defense Have The Appropriate Measures In Place To Protect Controlled Unclassified Information

NORTH BETHESDA, Md., March 19, 2025 (GLOBE NEWSWIRE) — Xometry (NASDAQ: XMTR), the global AI-powered marketplace connecting enterprise buyers with suppliers of manufacturing services, today announced it has become one of the first companies in any industry to achieve Cybersecurity Maturity Model Certification (CMMC Level 2), for adherence to rigorous cybersecurity and information security standards for the aerospace and defense industries as set forth by the U.S. Department of Defense.

The recently finalized CMMC framework requires contractors seeking to do business with the Department of Defense to comply with stringent cybersecurity requirements for protecting Controlled Unclassified Information (CUI), including ITAR-regulated export-controlled data, and to undergo an audit by a Certified Third-Party Assessor Organization (C3PAO). Xometry received a perfect score.

“Xometry’s CMMC Level 2 certification demonstrates our industry leadership, and reinforces our position as a trusted partner for domestic aerospace companies, defense agencies, and other organizations that require strict data protection measures,” said Tarit Mitra, Xometry’s head of cyber and information security. “In today’s complex and challenging landscape, protecting sensitive information is not just a regulatory requirement—it’s a critical component of maintaining trust with our customers and protecting sensitive information vital to our national security.”

Learn more about Xometry’s CMMC certification here and see its full list of U.S.-based certificates and registrations here.

Xometry’s two-sided, e-commerce marketplace plays a vital role in the rapid digital transformation of America’s manufacturing industry. Xometry’s proprietary technology shortens development cycles, drives efficiencies within corporate environments and helps companies create resilient supply chains. Xometry’s product portfolio includes its industry leading digital marketplace; popular Thomasnet^® industrial sourcing platform, and cloud-based tools and centralized project management software for large, mission-critical projects.

About Xometry


Xometry’s
 (NASDAQ:XMTR) AI-powered marketplace, popular Thomasnet^® industrial sourcing platform and suite of cloud-based services are rapidly digitizing the manufacturing industry. Xometry provides manufacturers the critical resources they need to grow their business and makes it easy for buyers to create locally resilient supply chains. The Xometry Instant Quoting Engine^® leverages millions of pieces of data to analyze complex parts in real-time, matches buyers with the right suppliers globally, and provides accurate pricing and lead times. Learn more at www.xometry.com or follow @xometry.

Contacts:

Media:
Matthew Hutchison
[email protected]

Investors:
Shawn Milne
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/28a9f48b-8e02-4cd7-ae76-9de6672dee95

MONTREAL, March 19, 2025 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) announced today that Glenn J. Chamandy, President & Chief Executive Officer; Luca Barile, Executive Vice-President and Chief Financial Officer; and Jessy Hayem, Senior Vice-President, Head of Investor Relations and Global Communications, will participate in a fireside chat and one-on-one meetings with investors at the 28^th Annual CIBC Retail and Consumer Conference in Toronto on Wednesday, March 26, 2025.

About Gildan

Gildan is a leading manufacturer of everyday basic apparel. The Company’s product offering includes activewear, underwear and socks, sold to a broad range of customers, including wholesale distributors, screenprinters or embellishers, as well as to retailers that sell to consumers through their physical stores and/or e-commerce platforms and to global lifestyle brand companies. The Company markets its products in North America, Europe, Asia Pacific, and Latin America, under a diversified portfolio of Company-owned brands including Gildan^®, American Apparel^®, Comfort Colors^®, GOLDTOE^®, and Peds^®, and under an exclusive licensing agreement for the printwear channel for Champion^®.

Gildan owns and operates vertically integrated, large-scale manufacturing facilities which are primarily located in Central America, the Caribbean, North America, and Bangladesh. Gildan operates with a strong commitment to industry-leading labour, environmental and governance practices throughout its supply chain in accordance with its comprehensive ESG program embedded in the Company’s long-term business strategy. More information about the Company and its ESG practices and initiatives can be found at www.gildancorp.com.